| Code | Description | Claims | Beneficiaries | Total Paid |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
57,140 |
49,077 |
$1.54M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22,962 |
19,163 |
$803K |
| 85027 |
|
148,174 |
78,117 |
$537K |
| 80053 |
Comprehensive metabolic panel |
85,206 |
56,991 |
$493K |
| 87150 |
|
953 |
873 |
$389K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28,459 |
24,520 |
$271K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28,393 |
24,465 |
$270K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
8,911 |
6,766 |
$259K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
57,580 |
33,029 |
$250K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
17,870 |
16,030 |
$199K |
| 83605 |
|
19,604 |
11,540 |
$196K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
23,881 |
21,231 |
$190K |
| 87481 |
|
8,352 |
5,351 |
$179K |
| 88312 |
|
11,551 |
7,996 |
$166K |
| 88307 |
|
1,743 |
1,672 |
$150K |
| 84484 |
|
22,074 |
18,092 |
$146K |
| 83735 |
|
36,597 |
15,668 |
$138K |
| 83880 |
|
7,482 |
5,971 |
$133K |
| 87660 |
|
25,333 |
21,679 |
$133K |
| 81513 |
|
4,514 |
3,999 |
$125K |
| 84703 |
|
28,593 |
26,355 |
$124K |
| 82330 |
|
7,485 |
2,757 |
$115K |
| 83690 |
|
27,816 |
24,686 |
$110K |
| 85730 |
|
26,645 |
19,131 |
$102K |
| 80076 |
|
18,906 |
15,621 |
$82K |
| 85610 |
|
31,945 |
24,185 |
$73K |
| 80069 |
|
16,639 |
6,368 |
$68K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,279 |
6,641 |
$66K |
| 87581 |
|
3,425 |
3,191 |
$64K |
| 84702 |
|
7,832 |
7,002 |
$63K |
| 81001 |
|
38,273 |
34,614 |
$61K |
| 88173 |
|
1,871 |
1,667 |
$60K |
| 86850 |
|
14,204 |
12,385 |
$60K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,687 |
3,565 |
$57K |
| 87486 |
|
3,279 |
3,110 |
$56K |
| 87653 |
|
6,937 |
6,115 |
$55K |
| 84100 |
|
22,142 |
9,035 |
$55K |
| 88304 |
|
3,932 |
3,601 |
$53K |
| 82550 |
|
13,967 |
11,537 |
$53K |
| 88342 |
|
2,784 |
2,295 |
$49K |
| 84132 |
|
10,380 |
4,719 |
$46K |
| 81025 |
|
11,344 |
10,857 |
$43K |
| 80047 |
|
7,335 |
6,239 |
$38K |
| 86140 |
|
13,494 |
8,325 |
$37K |
| 86901 |
|
20,419 |
18,214 |
$34K |
| 85379 |
|
4,881 |
3,184 |
$33K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,682 |
2,528 |
$33K |
| 80202 |
|
4,558 |
1,863 |
$31K |
| 86900 |
|
18,947 |
16,876 |
$31K |
| 87077 |
|
6,313 |
5,513 |
$30K |
| 82947 |
|
5,630 |
2,106 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,936 |
4,540 |
$28K |
| 88142 |
|
4,072 |
3,763 |
$28K |
| 88141 |
|
3,592 |
3,163 |
$28K |
| 87040 |
|
2,729 |
2,357 |
$26K |
| 87529 |
|
1,296 |
1,062 |
$26K |
| 80074 |
|
1,062 |
988 |
$25K |
| 80061 |
Lipid panel |
3,710 |
3,474 |
$25K |
| 85007 |
|
14,126 |
5,256 |
$25K |
| 82247 |
|
10,722 |
3,687 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,117 |
4,806 |
$24K |
| 87480 |
|
6,774 |
5,509 |
$24K |
| 87510 |
|
6,776 |
5,510 |
$24K |
| 85018 |
|
8,387 |
3,498 |
$22K |
| 85384 |
|
3,585 |
1,844 |
$21K |
| 87511 |
|
2,138 |
1,834 |
$20K |
| 81003 |
|
18,444 |
17,216 |
$20K |
| 82248 |
|
7,269 |
3,482 |
$20K |
| 87563 |
|
1,714 |
1,500 |
$19K |
| 86923 |
|
724 |
666 |
$18K |
| 82140 |
|
2,136 |
1,425 |
$17K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,710 |
3,542 |
$16K |
| 88341 |
|
1,150 |
881 |
$14K |
| 84112 |
|
690 |
617 |
$13K |
| 88360 |
|
191 |
149 |
$13K |
| 86920 |
|
391 |
333 |
$12K |
| 85049 |
|
4,024 |
2,175 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,349 |
1,155 |
$12K |
| 84439 |
|
2,559 |
2,263 |
$12K |
| 82077 |
|
1,782 |
1,655 |
$10K |
| 86880 |
|
3,503 |
3,228 |
$10K |
| 87640 |
|
853 |
716 |
$10K |
| 87430 |
|
1,548 |
1,506 |
$10K |
| 88356 |
|
59 |
54 |
$10K |
| 80055 |
|
321 |
306 |
$9K |
| 82728 |
|
1,142 |
948 |
$8K |
| 87625 |
|
1,263 |
1,054 |
$7K |
| 82962 |
|
2,726 |
713 |
$7K |
| 84145 |
|
721 |
479 |
$7K |
| 88185 |
|
67 |
55 |
$6K |
| 88112 |
|
1,077 |
943 |
$6K |
| 84295 |
|
5,690 |
1,995 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
934 |
912 |
$6K |
| 85014 |
|
3,353 |
2,065 |
$5K |
| 85045 |
|
2,408 |
1,428 |
$5K |
| 88720 |
|
1,835 |
1,422 |
$5K |
| 86780 |
|
612 |
587 |
$5K |
| 87088 |
|
1,534 |
1,472 |
$5K |
| 82435 |
|
4,865 |
1,795 |
$4K |
| 88313 |
|
308 |
204 |
$4K |
| 82607 |
|
449 |
424 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
226 |
209 |
$4K |
| 83550 |
|
973 |
888 |
$3K |
| 85651 |
|
1,773 |
1,471 |
$3K |
| 82570 |
|
1,632 |
1,406 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
834 |
769 |
$3K |
| 84478 |
|
1,038 |
432 |
$3K |
| 83540 |
|
998 |
913 |
$3K |
| 86803 |
|
445 |
407 |
$3K |
| 87808 |
|
405 |
389 |
$2K |
| 85390 |
|
771 |
409 |
$2K |
| 88314 |
|
55 |
54 |
$2K |
| 88189 |
|
147 |
113 |
$2K |
| 83615 |
|
542 |
364 |
$2K |
| 87070 |
|
355 |
292 |
$2K |
| 87210 |
|
2,005 |
1,759 |
$2K |
| 88302 |
|
133 |
125 |
$1K |
| 82565 |
|
884 |
522 |
$1K |
| 89051 |
|
502 |
412 |
$1K |
| 88363 |
|
279 |
258 |
$1K |
| 82746 |
|
140 |
134 |
$1K |
| 87205 |
|
331 |
262 |
$1K |
| 85652 |
|
733 |
674 |
$970.11 |
| 85060 |
|
157 |
128 |
$931.84 |
| 87186 |
|
224 |
212 |
$926.30 |
| 87147 |
|
332 |
289 |
$881.51 |
| 85576 |
|
17 |
14 |
$791.64 |
| 87420 |
|
119 |
116 |
$777.10 |
| 82010 |
|
148 |
141 |
$754.94 |
| 86593 |
|
318 |
310 |
$714.00 |
| 84550 |
|
238 |
190 |
$618.36 |
| 85097 |
|
52 |
40 |
$616.12 |
| 87340 |
|
162 |
153 |
$606.30 |
| 88311 |
|
211 |
154 |
$520.09 |
| 81002 |
|
306 |
199 |
$519.75 |
| 84436 |
|
128 |
121 |
$506.24 |
| 84155 |
|
947 |
785 |
$496.30 |
| 88184 |
|
67 |
55 |
$435.26 |
| 88300 |
|
143 |
130 |
$416.49 |
| 82945 |
|
206 |
168 |
$393.64 |
| 82533 |
|
30 |
27 |
$303.97 |
| 82150 |
|
87 |
75 |
$245.38 |
| 84300 |
|
105 |
92 |
$234.96 |
| 87177 |
|
49 |
43 |
$205.66 |
| 86705 |
|
38 |
36 |
$112.56 |
| 86709 |
|
38 |
36 |
$107.52 |
| 87075 |
|
27 |
25 |
$96.90 |
| 88108 |
|
22 |
18 |
$87.89 |
| 87102 |
|
12 |
12 |
$68.76 |
| 83935 |
|
12 |
12 |
$51.15 |
| 83930 |
|
14 |
14 |
$45.10 |
| 84156 |
|
22 |
17 |
$42.50 |
| 86308 |
|
13 |
12 |
$35.30 |
| 82009 |
|
13 |
12 |
$33.88 |
| 84520 |
|
90 |
62 |
$29.70 |
| 86592 |
|
14 |
12 |
$29.10 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
297 |
284 |
$0.00 |
| 80320 |
|
773 |
737 |
$0.00 |
| 80329 |
|
121 |
112 |
$0.00 |
| 87631 |
|
2,635 |
2,482 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,344 |
1,236 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
132 |
124 |
$0.00 |